META’s intellectual property portfolio exceeds its target of 200 patents for 2021 with a total of 247 patents

HALIFAX, NS / ACCESSWIRE / November 4, 2021 / Meta Materials Inc. (the “Company” or “META®”) (NASDAQ: MMAT) (FSE: MMAT) a developer of high performance functional materials and nanocomposites, today announced that the Company has significantly exceeded its target of ” reach 200 patents by 2021. Including the patents added with the acquisition of Nanotech, META now holds a total of 247 patents (154 issued patents and 93 pending applications, including three design applications) in 65 patent families, including 44 families include at least one granted patent. The total number of patents increased 166% from 93 in fiscal 2020, and the number of patent families more than doubled from 28 last year. The portfolio includes 34 issued patents and 21 pending applications in the United States, and 120 issued patents and 72 pending applications in 23 countries around the world.

“These additions to our intellectual property portfolio demonstrate META’s strong commitment to innovation in the field of high performance functional materials and nanocomposites, and the importance of protecting and maintaining the quality of our technological achievements. a break. We will continue to seek strong and broad protection for our innovations and anticipate the filing of at least 30 patent applications in 2022, ”said Shann Kerner, Director of Intellectual Property at META.

The acquisition of Nanotech brought 19 patent families, of which 16 families include at least one granted patent. The newly added patent families cover document authentication, nanofabrication (including electron beam lithography and nanoimprint processes), roll-to-roll scale fabrication systems, as well as plasmonic, diffractive and crystalline nanostructures. photonics. META’s patent families cover a wide range of technologies and applications including, but not limited to, large area holographic filtering, scanning holography, light capture for solar panels, large-area nanomaterials, near-field lithography, plasmon lithography, transparent metal mesh, radio wave imaging, non-invasive glucose detection and magnetic resonance imaging. META’s intellectual property supports and protects the company’s development work in a wide range of markets, including consumer electronics, augmented reality, solar power and lighting, automotive, aerospace, medical imaging, detection and communications.

“META is a platform company that develops sustainable and disruptive technologies and products in the rapidly growing field of high performance functional materials. We are committed to aggressively developing and defending our patent heritage to protect our position as leader, to take full advantage of business opportunities our patents ensure our innovations and to continue to develop our brands and trademarks, ”said Kenneth Rice, Chief Financial Officer and Executive Vice President of META.

About Meta Materials Inc.

META® delivers previously unattainable performance in a range of applications by inventing, designing, developing and manufacturing durable and highly functional materials. Our vast technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, health and wellness, aerospace, automotive and clean energy. Our nano-optical technology provides anti-counterfeiting security features for government documents and currencies and authentication for brands. Our achievements have been widely recognized, including being named Lux ​​Research Innovator of the Year in 2021. Find out more at

Forward-looking information

This press release contains forward-looking information or statements within the meaning of Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, of Section 21E of the Securities Exchange Act of 1934, as amended, and the Securities Litigation Reform Act of 1995, relating to the Company, Nanotech, their business and the transaction, which may include, but are not limited to, statements regarding business strategies, product development, expansion plans and operational activities of the Company and Nanotech, the expansion of production capacity, the benefits to the Company of the acquisition of Nanotech and the benefits of nanotechnology for the Company’s partners and within industries in which they operate. Often, but not always, forward-looking information can be identified by the use of words such as “potential”, “predicted”, “plans”, “seeks”, “plans”, “expect”, “intention”. “,” Anticipated “,” believes “,” develop “,” focused “,” extend “,” position “or variations (including negative variations) of these words and phrases, or statements that certain actions, events or results “could”, “could”, “should”, “may”, “would” or “will” be taken, occur or be achieved. These statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management of the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this press release may not occur and could differ materially due to known and unknown risk factors and uncertainties affecting the Company, including risks related to the potential benefits of the transaction with Nanotech, capabilities of Nanotech installation and expansion, the Company’s research and development projects, the market potential of the Company’s products and nanotechnology, the Company’s market position, scalability of capacity production capacity, the ability to new customer engagements, lead-time material selection programs, the ability to reduce production costs, improve metamaterial manufacturing capabilities and expand market reach to new applications and industries, the ability to accelerate commercialization plans, the possibility of new customer contracts, continuous engagement u the Nanotech team, the technology industry, market strategies and operational activities, and m management’s ability to manage and operate the business. Further details on these and other risks that may affect the business of the Company are described under the heading “Forward-looking statement” in the Company’s Form 8-K filed with the SEC on August 10, 2021, and under the heading “Risk Factors” in the Company’s Form 10-Q filed with the SEC on August 13, 2021, in the Company’s Form 10-K filed with the SEC on March 18, 2021 and in the filings subsequent reports made by Meta Materials with the SEC, which are available on the SEC’s website at Although the Company has attempted to identify material factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or or results differ from those anticipated, estimated or intended. Therefore, readers should not place undue reliance on forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company assumes no obligation to publicly update or revise any forward-looking statement, whether whether as a result of new information, events, or otherwise, except to the extent required by law.


Marc Komonoski
Senior Vice President
Full communications
Phone: 1-877-255-8483
Email: [email protected]

Media inquiries

Pierre Rob
Vice-President, Corporate Development and Communications
Meta Matériaux Inc.
[email protected]

THE SOURCE: Meta Matériaux Inc.

See the source version on


Meta Matériaux Inc. published this content on 04 November 2021 and is solely responsible for the information it contains. Distributed by Public, unedited and unmodified, on 04 November 2021 12:14:19 UTC.

Previous K-9 'hero' dogs now have a special burial site in the Highland Cemetery
Next ClearPoint Neuro to Present at Stifel Virtual Healthcare 2021 Conference

No Comment

Leave a reply

Your email address will not be published.